Key result
Intravenous zatebradine (0.25 or 1.0 mg/kg) significantly slowed ectopic ventricular rhythms by an average of 19% and 26%, respectively, in canine hearts 24 hours after coronary ligation.
Why the study?
Does zatebradine reduce ectopic ventricular rhythms in canine hearts 24 hours after LAD ligation?
Does zatebradine reduce ectopic ventricular rhythms in canine hearts 24 hours after LAD ligation?
Effect estimate: 19% or 26% reduction
Zatebradine significantly slows ectopic ventricular rhythms in a canine model of myocardial infarction, suggesting a role for i(f) currents in sustaining ventricular ectopy.
Arrhythmias occur 24 h after occlusion of the left anterior descending (LAD) coronary artery in the canine heart and have been attributed to the abnormal spontaneous activity in subendocardial Purkinje fibers, which are markedly depolarized. The major current underlying normal automaticity in these fibers is i(f). Although the i(f) activation range is generally considered to be more negative than the diastolic membrane potential in these depolarized fibers in infarcts, this activation range has been shown to shift in a positive direction in response to hormonal influences. Thus i(f) could still mediate automaticity in these fibers in infarcts. Furthermore, recent reports indicate that a depolarizing diastolic current, probably i(f), also can be measured in ventricular muscle during abnormal experimental conditions, which may occur during ischemia. To test whether there is a role of i(f) currents in sustaining ventricular ectopy, we administered the selective i(f) channel blocker, zatebradine, 24 h after LAD ligation in canine hearts. We report that intravenous injections of zatebradine (0.25 or 1.0 mg/kg) significantly slow ventricular rhythms (with average reductions of 19 or 26%, respectively). Moreover, because zatebradine also slows sinus nodal rate, it can lead to an increased incidence of ectopic beats. However, during right atrial pacing, when sinus slowing has no effect on ventricular rhythms, capture of ventricular rhythms occurs at lower rates in the presence of zatebradine. The reduction of capture threshold is comparable to the reduction in the rate of the ectopic rhythm. Thus zatebradine eliminated the arrhythmia when the right atrium was paced at the original sinus rate.
No takes yet. Share an insight, caveat, or question.
Lasker et al. (1997) studied Arrhythmias after coronary artery ligation. Zatebradine was evaluated on Ventricular rhythm rate (19% or 26% reduction). Intravenous zatebradine (0.25 or 1.0 mg/kg) significantly slowed ectopic ventricular rhythms by an average of 19% and 26%, respectively, in canine hearts 24 hours after coronary ligation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: